Cholesterol support that 
addresses risk evolution over time

Cholesterol support is designed to reflect how lipid risk evolves alongside other cardiometabolic risks over time. Members receive coordinated behavior change tools, education, and clinical oversight that align with their broader health profile, rather than treating cholesterol in isolation.

Cholesterol is a distinct clinical focus with its own learning paths, goals, tracking, and specialist oversight. While it may complement hypertension and other Omada programs, it is not a variation of existing care.

Yes. Cardiometabolic specialist oversight is built into the care model, consistent with Omada’s hypertension and diabetes programs. Care teams with a CDCES as a specialist, are trained to support high cholesterol and sustain lipid control.

Yes. Members can track self-reported medications and lab values, and receive education and coaching support aligned with their care plan from their doctor. The program is designed to complement a member’s prescribing clinician.

Eligibility is based on clinical criteria for dyslipidemia or elevated cholesterol. Omada’s cholesterol program may be offered to members enrolling specifically for lipid management or to members already engaged in other Omada cardiometabolic programs.

Members progress through outreach, enrollment, cholesterol-specific onboarding, and ongoing program engagement. The experience includes structured learning paths, SMART goals, tracking, coaching interactions, and community participation.

The program focuses on helping members act on their lipid risk through everyday behaviors: education, nutrition guidance, activity support, goal setting, and lab awareness.

Yes. Cholesterol support integrates behavior change tools spanning food, physical activity, medication adherence, and education—recognizing that lipid management is influenced by multiple daily behaviors.

Yes. Members can participate in topic-based communities and kickoff groups designed to reinforce learning, motivation, and sustained engagement.

Omada anticipates engagement patterns consistent with existing cardiometabolic programs.

Early cholesterol engagement is expected to demonstrate participation and improvements in health behaviors that support lipid management over time.

As reporting becomes available at sufficient scale, clients will receive aggregated enrollment, engagement, and outcomes reporting.

No. Cholesterol support is delivered within Omada’s existing platform and care model, without adding operational complexity for existing clients.